CRISPR “One Shot” Cell Therapy for Hemophilia Developed – Genetic Engineering & Biotechnology News
|
CRISPR “One Shot" Cell Therapy for Hemophilia Developed
Genetic Engineering & Biotechnology News Scientists at the Salk Institute have combined CRISPR-Cas9 gene editing with stem cell technology to generate a one-time, autologous cell therapy for the genetic blood clotting disorder hemophilia B. In vivo tests showed that gene-edited, stem cell … |
